Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

$ 7.00

4.6
(77)
In stock
Description

Frontiers Decoding TROP2 in breast cancer: significance, clinical implications, and therapeutic advancements

Persistent EGFR/K-RAS/SIAH pathway activation drives chemo-resistance and early tumor relapse in triple-negative breast cancer

Frontiers Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

Cancers, Free Full-Text

Retrospective study of transcriptomic profiling identifies Thai triple-negative breast cancer patients who may benefit from immune checkpoint and PARP inhibitors [PeerJ]

Cancers, Free Full-Text

Frontiers Current Triple-Negative Breast Cancer Subtypes: Dissecting the Most Aggressive Form of Breast Cancer

Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

Predictive Biomarkers of Neoadjuvant Chemotherapy in Breast Cancer

Cells, Free Full-Text

PDF) Practical classification of triple-negative breast cancer: intratumoral heterogeneity, mechanisms of drug resistance, and novel therapies

Cells, Free Full-Text